Regulating Pharmaceutical Industry Post COVID-19

Amila Rafique
Additional contact information
Amila Rafique: MPhil Scholar, PIDE

No 2021:42, PIDE Webinar Brief from Pakistan Institute of Development Economics

Abstract: Pakistan came into being in 1947; at that time, there was no pharmaceutical operating industry in the country. Now, Pakistan has almost 700 vibrant and forward-looking operating units of pharmaceuticals, including 24 multinationals (MNCs) companies. Around 70% finished the Pakistan pharmaceutical industry fulfills the medicine demand of the country. The share of the market is divided between national and international Pharmaceutical companies. From the previous decade, progressive growth has been shown by the pharmaceutical industry. The company can currently fabricate a variety of drugs oscillating from simple prescriptions to sophisticated oncology, biotech, and value-added generic compounds.

Keywords: Regulating; Pharmaceutical; Industry (search for similar items in EconPapers)
Pages: 6 pages
Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://pide.org.pk/pdfpideresearch/wb-063-regulat ... ry-post-covid-19.pdf First Version, 2021 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pid:wbrief:2021:42

Access Statistics for this paper

More papers in PIDE Webinar Brief from Pakistan Institute of Development Economics Contact information at EDIRC.
Bibliographic data for series maintained by Khurram Iqbal ().